189 related articles for article (PubMed ID: 18483237)
1. Genetic ablation of M3 muscarinic receptors attenuates murine colon epithelial cell proliferation and neoplasia.
Raufman JP; Samimi R; Shah N; Khurana S; Shant J; Drachenberg C; Xie G; Wess J; Cheng K
Cancer Res; 2008 May; 68(10):3573-8. PubMed ID: 18483237
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic muscarinic receptor activation augments murine intestinal epithelial cell proliferation and tumorigenesis.
Peng Z; Heath J; Drachenberg C; Raufman JP; Xie G
BMC Cancer; 2013 Apr; 13():204. PubMed ID: 23617763
[TBL] [Abstract][Full Text] [Related]
3. Divergent effects of muscarinic receptor subtype gene ablation on murine colon tumorigenesis reveals association of M3R and zinc finger protein 277 expression in colon neoplasia.
Cheng K; Xie G; Khurana S; Heath J; Drachenberg CB; Timmons J; Shah N; Raufman JP
Mol Cancer; 2014 Apr; 13():77. PubMed ID: 24694019
[TBL] [Abstract][Full Text] [Related]
4. Cyclophilin C-associated protein (CyCAP) knock-out mice spontaneously develop colonic mucosal hyperplasia and exaggerated tumorigenesis after treatment with carcinogen azoxymethane.
Torlakovic EE; Keeler V; Wang C; Lim HJ; Lining LA; Laferté S
BMC Cancer; 2009 Jul; 9():251. PubMed ID: 19627619
[TBL] [Abstract][Full Text] [Related]
5. Scopolamine treatment and muscarinic receptor subtype-3 gene ablation augment azoxymethane-induced murine liver injury.
Khurana S; Shah N; Cheng K; Shiu B; Samimi R; Belo A; Shant J; Drachenberg C; Wess J; Raufman JP
J Pharmacol Exp Ther; 2010 Jun; 333(3):639-49. PubMed ID: 20197374
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis.
Fichera A; Little N; Jagadeeswaran S; Dougherty U; Sehdev A; Mustafi R; Cerda S; Yuan W; Khare S; Tretiakova M; Gong C; Tallerico M; Cohen G; Joseph L; Hart J; Turner JR; Bissonnette M
Cancer Res; 2007 Jan; 67(2):827-35. PubMed ID: 17234795
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor is required for colonic tumor promotion by dietary fat in the azoxymethane/dextran sulfate sodium model: roles of transforming growth factor-{alpha} and PTGS2.
Dougherty U; Cerasi D; Taylor I; Kocherginsky M; Tekin U; Badal S; Aluri L; Sehdev A; Cerda S; Mustafi R; Delgado J; Joseph L; Zhu H; Hart J; Threadgill D; Fichera A; Bissonnette M
Clin Cancer Res; 2009 Nov; 15(22):6780-9. PubMed ID: 19903783
[TBL] [Abstract][Full Text] [Related]
8. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
[TBL] [Abstract][Full Text] [Related]
9. Parabacteroides distasonis attenuates tumorigenesis, modulates inflammatory markers and promotes intestinal barrier integrity in azoxymethane-treated A/J mice.
Koh GY; Kane AV; Wu X; Crott JW
Carcinogenesis; 2020 Jul; 41(7):909-917. PubMed ID: 32115637
[TBL] [Abstract][Full Text] [Related]
10. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
11. Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis.
Ma DW; Finnell RH; Davidson LA; Callaway ES; Spiegelstein O; Piedrahita JA; Salbaum JM; Kappen C; Weeks BR; James J; Bozinov D; Lupton JR; Chapkin RS
Cancer Res; 2005 Feb; 65(3):887-97. PubMed ID: 15705887
[TBL] [Abstract][Full Text] [Related]
12. Neutrophils Restrict Tumor-Associated Microbiota to Reduce Growth and Invasion of Colon Tumors in Mice.
Triner D; Devenport SN; Ramakrishnan SK; Ma X; Frieler RA; Greenson JK; Inohara N; Nunez G; Colacino JA; Mortensen RM; Shah YM
Gastroenterology; 2019 Apr; 156(5):1467-1482. PubMed ID: 30550822
[TBL] [Abstract][Full Text] [Related]
13. Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of beta-catenin mutation.
Suzui M; Okuno M; Tanaka T; Nakagama H; Moriwaki H
Cancer Lett; 2002 Sep; 183(1):31-41. PubMed ID: 12049812
[TBL] [Abstract][Full Text] [Related]
14. Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen.
Singh P; Velasco M; Given R; Varro A; Wang TC
Gastroenterology; 2000 Jul; 119(1):162-71. PubMed ID: 10889165
[TBL] [Abstract][Full Text] [Related]
15. Colon carcinogenesis in wild type and immune compromised mice after treatment with azoxymethane, and azoxymethane with dextran sodium sulfate.
Whetstone RD; Wittel UA; Michels NM; Gulizia JM; Gold B
Mol Carcinog; 2016 Jul; 55(7):1187-95. PubMed ID: 26153082
[TBL] [Abstract][Full Text] [Related]
16. Gastrin-releasing peptide is a mitogen and a morphogen in murine colon cancer.
Carroll RE; Matkowskyj KA; Tretiakova MS; Battey JF; Benya RV
Cell Growth Differ; 2000 Jul; 11(7):385-93. PubMed ID: 10939592
[TBL] [Abstract][Full Text] [Related]
17. Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6.
Luo Y; Xie C; Brocker CN; Fan J; Wu X; Feng L; Wang Q; Zhao J; Lu D; Tandon M; Cam M; Krausz KW; Liu W; Gonzalez FJ
Gastroenterology; 2019 Sep; 157(3):744-759.e4. PubMed ID: 31154022
[TBL] [Abstract][Full Text] [Related]
18. Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors.
Guda K; Giardina C; Nambiar P; Cui H; Rosenberg DW
Mol Carcinog; 2001 Aug; 31(4):204-13. PubMed ID: 11536370
[TBL] [Abstract][Full Text] [Related]
19. Deletion of functional gastrin gene markedly increases colon carcinogenesis in response to azoxymethane in mice.
Cobb S; Wood T; Tessarollo L; Velasco M; Given R; Varro A; Tarasova N; Singh P
Gastroenterology; 2002 Aug; 123(2):516-30. PubMed ID: 12145805
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer.
Biswas S; Chytil A; Washington K; Romero-Gallo J; Gorska AE; Wirth PS; Gautam S; Moses HL; Grady WM
Cancer Res; 2004 Jul; 64(14):4687-92. PubMed ID: 15256431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
